Publications

Gearhart JM, Covington TR, Robinson PJ, Whalley CE, McGuire JM, Evans RA, et al. Simulation of VX exposure in multiple species by means of a physiologically based pharmacokinetic/pharmacodynamic model. Poster presented at the Bioscience Review Conference, Baltimore, MD, May 2008.

Staskal DF, Tachovsky JA, Harris MA, Haws LC. 2008. Preliminary evaluation of human health risk associated with exposure to PBDEs in the United States. Presented at Dioxin 2008, August 17-22, Birmingham, England.

Tachovsky JA, Harris MA, Staskal DF, Scott LF, Luksemburg WJ, Paustenbach DP, Haws LC. Analysis of fish tissue concentrations of dioxins and furans using principal components analysis. Presented at Dioxin 2008, Birmingham, England, August 2008.

Kreider ML, Unice KM, Panko JM, Burns AM, Widner TE, Paustenbach DJ, Booher LE, Gelatt RH, Gaffney SH. Occupational exposure to benzene the ExxonMobil refinery in Joliet, Illinois (1977-2006). Abstract 227, Society of Toxicology 47^th Annual Meeting. Abstract 227, Seattle, WA, March 2008.

Stokes W, Allen D, Burns T, Choksi N, Matheson, J, Jacobs, Tice, R. Performance characteristics of the local lymph node assay (llna) limit dose procedure. Poster presented at Society of Toxicology 47th Annual Meeting, Seattle, WA, March 2008.

Tachovsky JA, Staskal DF, Harris MA, Scott LF, Luksemburg WJ, Paustenbach DP, Haws LC. 2008. Principal components analysis of PBDE concentrations in fish tissue from southern Mississippi. Presented at Dioxin 2008, August 17-22, Birmingham, England.

Hinerman J. Crystallographic and small angle scattering studies of the bacteriophage T4 replication complex. Invited presentation to American Crystallographic Association Annual Meeting, Knoxville, TN, June 2008.

Urban JD, Haws LC, Staskal DF, Scott LF, Scott PS, Tachovsky AT, Unice KM, Harris MA. A framework for evaluating serum dioxin data derived from biomonitoring studies. Presented at Dioxin 2008, Birmingham, England, August 17-22 2008.

Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.

Robison TW. Case examples of qualification of extractables and leachables in therapeutic biologic products: A toxicological perspective. WCBP CMC Strategy Forum–Extractables and Leachables: Challenges and Strategies in Biopharmaceutical Development (Sponsored by CASSS and the United States Food and Drug Administration), Washington, DC, January 2008.

Panko JM, Unice KM, Shay EC. Recommendations for developing child-focused exposure assessments based on VCCEP experiences. Society for Risk Analysis, December 2007.

DeSesso J, Watson RE, Keen CL, Hazleden KP, Haws LC, Li AA. Integration of developmental toxicity data into risk assessment: A case study of dimethoate. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

Diliberto JJ, Staskal DF, Hakk H, Birnbaum LS. Differential urinary protein binding of PBDEs in mice. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

Robison TW. Toxicology in the nonclinical development of drugs and biologics. Pharmaceutical Education and Research Institute, Genetic Toxicology, Arlington, VA, September 2007.

Dwyer M, Perry C, Jenkins, A. Trichloroethylene toxicity and risks: Recent developments and potential implications. Presented at Texas Association of Environmental Professionals — Environmental Challenges and Innovations Conference, February 2007.

Kulpa-Eddy J, Jacobs A, Halder M, Burns T, Choksi N, Allen D, et al. Alternatives to the mouse LD50 assay for botulinum toxin testing: An ICCVAM/NICEATM/ECVAM sponsored workshop. Poster presented at the 6th World Congress on Alternatives and Animal Use in the Life Sciences, Tokyo, Japan, August 2007.

Choksi N, Haseman J, Truax J, Wnorowski G, Merkel D, Stokes W. Topical anesthetic pre-treatment in the Draize eye test: Impact on hazard classification. Poster presented at the 6th World Congress on Alternatives and Animal Use in the Life Sciences, Tokyo, Japan, August 2007.

Tice R, Allen D, Choksi N, Truax J, Stokes W. Relationship between adverse ocular effects and their reversibility. Poster presented at the 6th World Congress on Alternatives and Animal Use in the Life Sciences, Tokyo, Japan, August 2007.

Emond C, Raymer J, Garner E, Diliberto J, Staskal D, Birnbaum LS. A physiologically-based pharmacokinetic model for developmental exposure to PBDE-47 in rodents. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

Panko JM, Unice KM, Shay EC. Javier AF. Assessment of children’s exposures to toluene. Society of Toxicology 46th Annual Meeting, March 2007.